Bridges Investment Management Cut Biogen Com (BIIB) Stake; Last Week Anglo American plc (LON:AAL) Coverage

February 17, 2018 - By Jerrie Dane

Among 27 analysts covering Anglo American PLC (LON:AAL), 12 have Buy rating, 5 Sell and 10 Hold. Therefore 44% are positive. Anglo American PLC has GBX 2200 highest and GBX 152 lowest target. GBX 1274.88’s average target is -27.09% below currents GBX 1748.6 stock price. Anglo American PLC had 484 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Anglo American plc (LON:AAL) has “Hold” rating given on Wednesday, December 16 by Deutsche Bank. The firm has “Buy” rating given on Thursday, May 4 by HSBC. Bernstein maintained Anglo American plc (LON:AAL) on Thursday, January 14 with “Outperform” rating. The rating was maintained by JP Morgan with “Overweight” on Thursday, January 11. Deutsche Bank maintained Anglo American plc (LON:AAL) on Wednesday, December 9 with “Buy” rating. The stock of Anglo American plc (LON:AAL) has “Hold” rating given on Monday, October 19 by HSBC. The stock of Anglo American plc (LON:AAL) earned “Neutral” rating by BNP Paribas on Wednesday, November 18. The company was maintained on Monday, August 24 by Morgan Stanley. As per Thursday, May 5, the company rating was maintained by JP Morgan. The stock has “Sell” rating by Liberum Capital on Wednesday, July 20. See Anglo American plc (LON:AAL) latest ratings:

16/02/2018 Broker: RBC Capital Markets Rating: Outperform Old Target: GBX 2050.00 New Target: GBX 2200.00 Maintain
15/02/2018 Broker: Credit Suisse Rating: Neutral Maintain
14/02/2018 Broker: Deutsche Bank Rating: Hold Old Target: GBX 1550.00 New Target: GBX 1550.00 Maintain
07/02/2018 Broker: JP Morgan Rating: Overweight New Target: GBX 1920.00 Maintain
25/01/2018 Broker: Liberum Capital Rating: Sell Old Target: GBX 800.00 New Target: GBX 800.00 Maintain
23/01/2018 Broker: Macquarie Research Rating: Outperform New Target: GBX 2100.00 Upgrade
15/01/2018 Broker: Deutsche Bank Rating: Hold Old Target: GBX 1400.00 New Target: GBX 1550.00 Maintain
15/01/2018 Broker: Liberum Capital Rating: Sell Old Target: GBX 800.00 New Target: GBX 800.00 Maintain
11/01/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 1620.00 New Target: GBX 1670.00 Maintain
11/01/2018 Broker: Morgan Stanley Rating: Overweight Old Target: GBX 1600.00 New Target: GBX 1900.00 Upgrade

Bridges Investment Management Inc decreased Biogen Inc Com (BIIB) stake by 7.88% reported in 2017Q3 SEC filing. Bridges Investment Management Inc sold 970 shares as Biogen Inc Com (BIIB)’s stock declined 13.45%. The Bridges Investment Management Inc holds 11,340 shares with $3.55M value, down from 12,310 last quarter. Biogen Inc Com now has $61.75 billion valuation. The stock decreased 2.51% or $7.51 during the last trading session, reaching $291.87. About 2.94M shares traded or 122.72% up from the average. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 17, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Since January 9, 2018, it had 0 insider purchases, and 1 insider sale for $1.92 million activity. On Tuesday, January 9 PANGIA ROBERT W sold $1.92M worth of Biogen Inc. (NASDAQ:BIIB) or 5,832 shares.

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.25, from 0.88 in 2017Q2. It improved, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Global X Ltd Liability owns 3,936 shares. Seaward Mngmt Ltd Partnership holds 0.01% or 843 shares. Winslow Capital Ltd Liability Corp holds 682,672 shares. Security National Trust holds 0.02% or 217 shares. Mcf Advsr Ltd Liability Company invested in 208 shares or 0.01% of the stock. Guardian Investment Management holds 11,165 shares. Qci Asset Management Incorporated has invested 0.01% in Biogen Inc. (NASDAQ:BIIB). Seizert Capital Prtnrs Lc reported 99,255 shares. 725 were accumulated by Edgemoor Inv Advsr Inc. Buckingham Capital Mgmt, a Alabama-based fund reported 2,723 shares. Amica Pension Fund Board Of Trustees owns 8,280 shares or 0.31% of their US portfolio. Natixis has invested 0.21% in Biogen Inc. (NASDAQ:BIIB). The United Kingdom-based Gulf National Bank (Uk) Ltd has invested 0.29% in Biogen Inc. (NASDAQ:BIIB). Silvercrest Asset Mgmt Group Limited Liability Co owns 0.01% invested in Biogen Inc. (NASDAQ:BIIB) for 2,117 shares. Singapore-based Temasek Hldgs (Private) Limited has invested 0.22% in Biogen Inc. (NASDAQ:BIIB).

Among 33 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 24 have Buy rating, 0 Sell and 9 Hold. Therefore 73% are positive. Biogen Idec Inc. has $450 highest and $268 lowest target. $372.67’s average target is 27.68% above currents $291.87 stock price. Biogen Idec Inc. had 113 analyst reports since July 23, 2015 according to SRatingsIntel. Canaccord Genuity maintained Biogen Inc. (NASDAQ:BIIB) on Wednesday, January 24 with “Hold” rating. The firm has “Hold” rating given on Friday, December 9 by Stifel Nicolaus. The stock of Biogen Inc. (NASDAQ:BIIB) has “Hold” rating given on Monday, June 12 by Jefferies. The rating was maintained by RBC Capital Markets on Monday, July 27 with “Outperform”. On Tuesday, October 24 the stock rating was maintained by Goldman Sachs with “Buy”. The rating was maintained by H.C. Wainwright with “Buy” on Thursday, October 22. Morgan Stanley downgraded Biogen Inc. (NASDAQ:BIIB) rating on Thursday, March 16. Morgan Stanley has “Equal-Weight” rating and $305 target. Cowen & Co maintained the stock with “Buy” rating in Tuesday, July 25 report. The firm has “Outperform” rating given on Wednesday, October 25 by BMO Capital Markets. On Monday, November 7 the stock rating was upgraded by Leerink Swann to “Outperform”.

The stock increased 1.31% or GBX 22.6 during the last trading session, reaching GBX 1748.6. About 5.41M shares traded. Anglo American plc (LON:AAL) has 0.00% since February 17, 2017 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment decreased to 0.66 in 2017 Q3. Its down 0.25, from 0.91 in 2017Q2. It is negative, as 53 investors sold Anglo American plc shares while 210 reduced holdings. 55 funds opened positions while 118 raised stakes. 380.49 million shares or 2.17% less from 388.91 million shares in 2017Q2 were reported. Granite Partners Llc has 0.01% invested in Anglo American plc (LON:AAL). Federated Invsts Pa holds 0% or 13,153 shares in its portfolio. Teachers Insurance Annuity Association Of America, New York-based fund reported 473,724 shares. Reilly Financial Advisors Ltd Liability Company has invested 0.07% in Anglo American plc (LON:AAL). 37,455 were reported by Allen Invest Management Ltd Liability Corporation. Daiwa Secs Group Inc reported 0.01% stake. New York-based First Manhattan has invested 0% in Anglo American plc (LON:AAL). Marco Ltd stated it has 101,280 shares. Employees Retirement Systems Of Texas has invested 0.03% in Anglo American plc (LON:AAL). 41,140 were accumulated by World Asset Mngmt Incorporated. Public Employees Retirement Systems Of Ohio owns 209,902 shares or 0.05% of their US portfolio. Williams Jones And Assoc Limited Liability Com holds 61,213 shares or 0.07% of its portfolio. D E Shaw Com Inc has 111,464 shares. 92,563 were reported by Barnett & Com. State Of Wisconsin Invest Board reported 0.03% of its portfolio in Anglo American plc (LON:AAL).